Systemic vaccination induces CD8+ T cells and remodels the tumor microenvironment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic vaccination induces CD8+ T cells and remodels the tumor microenvironment
Authors
Keywords
-
Journal
CELL
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-10-26
DOI
10.1016/j.cell.2022.10.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
- (2021) Sijin Cheng et al. CELL
- MDSC: Markers, development, states, and unaddressed complexity
- (2021) Samarth Hegde et al. IMMUNITY
- Integrated analysis of multimodal single-cell data
- (2021) Yuhan Hao et al. CELL
- Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease
- (2021) Kevin Mulder et al. IMMUNITY
- A single-cell and spatially resolved atlas of human breast cancers
- (2021) Sunny Z. Wu et al. NATURE GENETICS
- Immunoregulatory Monocyte Subset Promotes Metastasis Associated With Therapeutic Intervention for Primary Tumor
- (2021) Takumi Shibuya et al. Frontiers in Immunology
- Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
- (2021) Khiem C. Lam et al. CELL
- Discovering dominant tumor immune archetypes in a pan-cancer census
- (2021) Alexis J. Combes et al. CELL
- Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity
- (2021) Ellen Duong et al. IMMUNITY
- Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting
- (2021) Tetiana Hourani et al. Frontiers in Oncology
- Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
- (2020) Anthony R. Cillo et al. IMMUNITY
- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens
- (2020) Geoffrey M. Lynn et al. NATURE BIOTECHNOLOGY
- Classical Activation of Macrophages Leads to Lipid Droplet Formation Without de novo Fatty Acid Synthesis
- (2020) Mauricio Rosas-Ballina et al. Frontiers in Immunology
- Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer
- (2020) Lei Zhang et al. CELL
- A conserved dendritic-cell regulatory program limits antitumour immunity
- (2020) Barbara Maier et al. NATURE
- Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer
- (2020) Hae-Ock Lee et al. NATURE GENETICS
- Systemic dysfunction and plasticity of the immune macroenvironment in cancer models
- (2020) Breanna M. Allen et al. NATURE MEDICINE
- Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma
- (2020) Nayoung Kim et al. Nature Communications
- Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer
- (2020) Mehdi Chaib et al. Frontiers in Cell and Developmental Biology
- Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer
- (2020) Yonatan Katzenelenbogen et al. CELL
- TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy
- (2020) Martina Molgora et al. CELL
- Determinants of Resident Tissue Macrophage Identity and Function
- (2020) Camille Blériot et al. IMMUNITY
- Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular Carcinoma
- (2020) Ankur Sharma et al. CELL
- Poly-ICLC, a multi-functional immune modulator for treating cancer
- (2020) Hussein Sultan et al. SEMINARS IN IMMUNOLOGY
- Tackling TAMs for Cancer Immunotherapy: It’s Nano Time
- (2020) Yishun Yang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Triacylglycerol synthesis enhances macrophage inflammatory function
- (2020) Angela Castoldi et al. Nature Communications
- dittoSeq: universal user-friendly single-cell and bulk RNA sequencing visualization toolkit
- (2020) Daniel G Bunis et al. BIOINFORMATICS
- Interferons α and β in cancer: therapeutic opportunities from new insights
- (2019) Ernest C. Borden NATURE REVIEWS DRUG DISCOVERY
- Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species
- (2019) Rapolas Zilionis et al. IMMUNITY
- DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors
- (2019) Christopher S. McGinnis et al. Cell Systems
- Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner
- (2019) Diego Adhemar Jaitin et al. CELL
- Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma
- (2019) Junya Peng et al. CELL RESEARCH
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
- (2019) Yingyao Zhou et al. Nature Communications
- NicheNet: modeling intercellular communication by linking ligands to target genes
- (2019) Robin Browaeys et al. NATURE METHODS
- Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
- (2018) Elham Azizi et al. CELL
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Phenotype molding of stromal cells in the lung tumor microenvironment
- (2018) Diether Lambrechts et al. NATURE MEDICINE
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy
- (2018) Matthew M. Gubin et al. CELL
- Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
- (2016) Se Jin Im et al. NATURE
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- The Human Vaccines Project: A roadmap for cancer vaccine development
- (2016) Pedro Romero et al. Science Translational Medicine
- Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
- (2016) Suzanne I.S. Mosely et al. Cancer Immunology Research
- Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site
- (2015) Maxime Thoreau et al. Oncotarget
- Therapeutic Peptide Vaccine-Induced CD8 T Cells Strongly Modulate Intratumoral Macrophages Required for Tumor Regression
- (2015) T. C. van der Sluis et al. Cancer Immunology Research
- Therapeutic vaccines for cancer: an overview of clinical trials
- (2014) Ignacio Melero et al. Nature Reviews Clinical Oncology
- The association of annexin A2 and cancers
- (2012) Xiaohui Zhang et al. Clinical & Translational Oncology
- Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage
- (2012) Matthew M. Meredith et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PGE2 Induces Macrophage IL-10 Production and a Regulatory-like Phenotype via a Protein Kinase A-SIK-CRTC3 Pathway
- (2012) K. F. MacKenzie et al. JOURNAL OF IMMUNOLOGY
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferons inhibit the generation of tumor-associated macrophages
- (2009) Lance U’Ren et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
- (2009) Steffen Durinck et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now